359 related articles for article (PubMed ID: 21169257)
1. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.
Schreck KC; Taylor P; Marchionni L; Gopalakrishnan V; Bar EE; Gaiano N; Eberhart CG
Clin Cancer Res; 2010 Dec; 16(24):6060-70. PubMed ID: 21169257
[TBL] [Abstract][Full Text] [Related]
2. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma.
Bar EE; Chaudhry A; Lin A; Fan X; Schreck K; Matsui W; Piccirillo S; Vescovi AL; DiMeco F; Olivi A; Eberhart CG
Stem Cells; 2007 Oct; 25(10):2524-33. PubMed ID: 17628016
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.
Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR
Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog signaling in glioblastoma multiforme.
Braun S; Oppermann H; Mueller A; Renner C; Hovhannisyan A; Baran-Schmidt R; Gebhardt R; Hipkiss A; Thiery J; Meixensberger J; Gaunitz F
Cancer Biol Ther; 2012 May; 13(7):487-95. PubMed ID: 22406999
[TBL] [Abstract][Full Text] [Related]
5. Sonic Hedgehog regulates Hes1 through a novel mechanism that is independent of canonical Notch pathway signalling.
Ingram WJ; McCue KI; Tran TH; Hallahan AR; Wainwright BJ
Oncogene; 2008 Feb; 27(10):1489-500. PubMed ID: 17873912
[TBL] [Abstract][Full Text] [Related]
6. Progenitor cell proliferation in the retina is dependent on Notch-independent Sonic hedgehog/Hes1 activity.
Wall DS; Mears AJ; McNeill B; Mazerolle C; Thurig S; Wang Y; Kageyama R; Wallace VA
J Cell Biol; 2009 Jan; 184(1):101-12. PubMed ID: 19124651
[TBL] [Abstract][Full Text] [Related]
7. Polyethylenimine-Spherical Nucleic Acid Nanoparticles against Gli1 Reduce the Chemoresistance and Stemness of Glioblastoma Cells.
Melamed JR; Ioele SA; Hannum AJ; Ullman VM; Day ES
Mol Pharm; 2018 Nov; 15(11):5135-5145. PubMed ID: 30260647
[TBL] [Abstract][Full Text] [Related]
8. Notch signaling activation in pediatric low-grade astrocytoma.
Brandt WD; Schreck KC; Bar EE; Taylor I; Marchionni L; Raabe E; Eberhart CG; Rodriguez FJ
J Neuropathol Exp Neurol; 2015 Feb; 74(2):121-31. PubMed ID: 25575134
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines.
Ferruzzi P; Mennillo F; De Rosa A; Giordano C; Rossi M; Benedetti G; Magrini R; Pericot Mohr Gl; Miragliotta V; Magnoni L; Mori E; Thomas R; Tunici P; Bakker A
Int J Cancer; 2012 Jul; 131(2):E33-44. PubMed ID: 22072503
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway.
Wu J; Ji Z; Liu H; Liu Y; Han D; Shi C; Shi C; Wang C; Yang G; Chen X; Shen C; Li H; Bi Y; Zhang D; Zhao S
Toxicol Lett; 2013 Jun; 220(1):61-9. PubMed ID: 23542114
[TBL] [Abstract][Full Text] [Related]
11. A combined gene signature of hypoxia and notch pathway in human glioblastoma and its prognostic relevance.
Irshad K; Mohapatra SK; Srivastava C; Garg H; Mishra S; Dikshit B; Sarkar C; Gupta D; Chandra PS; Chattopadhyay P; Sinha S; Chosdol K
PLoS One; 2015; 10(3):e0118201. PubMed ID: 25734817
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
[TBL] [Abstract][Full Text] [Related]
13. Essential role of Gli proteins in glioblastoma multiforme.
Santoni M; Burattini L; Nabissi M; Morelli MB; Berardi R; Santoni G; Cascinu S
Curr Protein Pept Sci; 2013 Mar; 14(2):133-40. PubMed ID: 23544423
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog signaling pathway is active in GBM with GLI1 mRNA expression showing a single continuous distribution rather than discrete high/low clusters.
Chandra V; Das T; Gulati P; Biswas NK; Rote S; Chatterjee U; Ghosh SN; Deb S; Saha SK; Chowdhury AK; Ghosh S; Rudin CM; Mukherjee A; Basu A; Dhara S
PLoS One; 2015; 10(3):e0116390. PubMed ID: 25775002
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.
Chen M; Feuerstein MA; Levina E; Baghel PS; Carkner RD; Tanner MJ; Shtutman M; Vacherot F; Terry S; de la Taille A; Buttyan R
Mol Cancer; 2010 Apr; 9():89. PubMed ID: 20420697
[TBL] [Abstract][Full Text] [Related]
16. CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway.
Chen J; Lv H; Hu J; Ji M; Xue N; Li C; Ma S; Zhou Q; Lin B; Li Y; Yu S; Chen X
Cancer Lett; 2016 Oct; 381(2):391-403. PubMed ID: 27495899
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Sonic hedgehog signaling and WW domain containing oxidoreductase WOX1 expression enhances radiosensitivity of human glioblastoma cells.
Chiang MF; Chen HH; Chi CW; Sze CI; Hsu ML; Shieh HR; Lin CP; Tsai JT; Chen YJ
Exp Biol Med (Maywood); 2015 Mar; 240(3):392-9. PubMed ID: 25595187
[TBL] [Abstract][Full Text] [Related]
18. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
[TBL] [Abstract][Full Text] [Related]
19. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma.
Yoon JW; Gallant M; Lamm ML; Iannaccone S; Vieux KF; Proytcheva M; Hyjek E; Iannaccone P; Walterhouse D
Mol Cancer Res; 2013 Jun; 11(6):604-15. PubMed ID: 23525267
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level.
Munoz JL; Rodriguez-Cruz V; Ramkissoon SH; Ligon KL; Greco SJ; Rameshwar P
Oncotarget; 2015 Jan; 6(2):1190-201. PubMed ID: 25595896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]